JB/CALL/POLE GROU/25/0.1/21.06.24 Stock

PPYGJB

CH1284780900

Real-time Bid/Ask 06:20:55 2024-05-28 EDT
0.92 ^CHF / 0.93 ^CHF	+14.20%

Current month	+22.73%
1 month	+44.64%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart POLYPEPTIDE GROUP AG

Latest news about POLYPEPTIDE GROUP AG

PolyPeptide : and Donaldson collaborate to develop solvent recovery system for peptide purification	05-13	PU
Hamlet BioPharma secures large scale Alpha1 peptide production in an agreement with Polypeptide Group	04-18	AQ
PolyPeptide announces results of the annual General Meeting 2024	04-10	EQ
PolyPeptide publishes invitation to the annual General Meeting 2024	03-19	EQ

More news

Quotes 5-day view

Date	Price	Change
24-05-27	0.81	+8.00%
24-05-24	0.75	-7.41%
24-05-22	0.81	-1.22%

Delayed Quote Swiss Exchange

Last update May 27, 2024 at 11:20 am

More quotes

Static data

Product type	Plain-Vanilla-Warrants
Buy / Sell	CALL
Underlying	POLYPEPTIDE GROUP AG
Issuer	Bank Julius Bär
	PPYGJB
ISIN	CH1284780900
Date issued	2023-08-23
Strike	25 CHF
Maturity	2024-06-21 (25 Days)
Parity	10 : 1
Emission price	0.56 CHF
Emission volume	N/A
Settlement	both
Currency	CHF

Technical Indicators

Highest since issue	0.9 CHF
Lowest since issue	0.03 CHF
Spread	0.01 CHF
Spread %	1.12%

Company Profile

Polypeptide Group AG is a Switzerland-based Contract Development & Manufacturing Organization (CDMO) focusing on proprietary and generic GMP-grade peptides used by pharmaceutical and biotech companies in approved pharmaceutical products, drugs in clinical development as well as in generic products.

Sector

More about the company

Ratings for PolyPeptide Group AG

Trading Rating

Investor Rating

ESG Refinitiv

B-

More Ratings

Consensus: PolyPeptide Group AG

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

33.26 EUR

Average target price

25.12 EUR

Spread / Average Target

-24.46%

Consensus